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Introduction
Adult stem cell migration through human hematopoietic
tissue requires the chemokine CXCL12 and its receptor
CXCR4. In addition, human leukocyte elastase (HLE)
plays a key role. When HLE is located on the cell surface
(HLECS), it acts not as a proteinase, but as a receptor for
a1proteinase inhibitor (a1PI, a1antitrypsin). Binding of
a1PI to HLECS forms a motogenic complex. We pre-
viously demonstrated that a1PI deficiency attends HIV-1
disease. Here we investigate the mechanism and therapeu-
tically address the a1PI deficiency of HIV-1 infection.
Materials and methods
Blood was collected from 30 HIV-1 uninfected and 39
HIV-1 infected adults. Residual sera was obtained from 20
HIV-1 uninfected chimpanzees, 2 chimpanzees pre- and
42 months post-HIV-1 challenge, 12 HIV-1-immunized
macaques, and 3 SHIV-infected macaques. Three HIV-1
infected individuals received a1PI augmentation therapy.
Results
In HIV-1 uninfected individuals, CD4
+ lymphocytes were
correlated with the combined factors a1PI, HLECS+ lym-
phocytes, and CXCR4+ lymphocytes (r
2 = 0.91, p < 0.001,
n = 30), but not CXCL12. In contrast, in HIV-1 individuals
with >220 CD4 cells/µl, CD4+ lymphocytes were corre-
lated solely with active a1PI (r
2 = 0.93, p < 0.0001, n =
26). The monoclonal anti-HIV-1 antibody 3F5 present in
HIV-1 patient blood bound and inactivated human a1PI.
Chimpanzee a1PI differs from human a1P Ib yas i n g l e
amino acid which lies within the 3F5-binding epitope.
Unlike human a1PI, neither chimpanzee nor macaque
a1PI bound to 3F5, nor was a1PI depleted following HIV-
1 challenge, consistent with the normal CD4
+ lymphocyte
numbers of HIV-1 infected chimpanzees. The presence of
IgG- a1PI immune complexes correlated with decreased
CD4
+ lymphocytes in HIV-1 individuals, and a1PI aug-
mentation quadrupled the number of immunocompetent
CD4
+ lymphocytes with no untoward effects.
Conclusions
An autoimmune component of HIV-1 disease was identi-
fied and was overcome therapeutically. Results identify an
achievable vaccine modification with the novel objective to
protect against AIDS as opposed to the current objective
to protect against HIV-1 infection.
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